Could a common cholesterol drug improve recovery after cancer surgery?
NCT ID NCT01169051
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviewed the medical records of 569 adults who had surgery for lung or esophageal cancer. Researchers wanted to see if taking statins (cholesterol-lowering drugs) around the time of surgery was linked to fewer complications and better long-term outcomes. The goal is to find out if a simple, inexpensive drug could help patients recover more smoothly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- statins
- What this could lead to
- If statins are found to improve recovery, this could point toward a simple way to reduce complications after thoracic cancer surgery.
- What could go wrong
- This is a retrospective review, not a controlled trial, so it can only show an association, not prove cause and effect. Results may not lead to changes in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Blood test score may flag High-Risk esophageal surgery patients
- Your Tumor's DNA might predict immunotherapy success